View Single Post
Loose Cannon
In 1991, WHO presented the results of a study of over 11,000 women who used Depo-Provera, mainly in Thailand and New Zealand. (The drug has been approved for contraception in about 90 countries.) Based on the study, published in the Oct. 5, 1991, issue of The Lancet, WHO concluded that, overall, women on Depo-Provera are not at increased risk of breast cancer. In addition, breast cancer risk did not increase the longer a woman stayed on the injectable contraceptive. The study did find a slight increase in the risk of breast cancer during the first four years of use, primarily in women under 35. That increase, however, is statistically weak and comparable to the risk associated with oral contraceptives, according to the researchers.
Google search

On the plus side, Depo has been shown to greatly reduce the likelihood of endometrial cancer (cancer of the uterus lining).
Birth control questions? Read

"wow.. a 22k thread that doesnt suck" - jewbloob

Chief [M]icrosoft Hater of Gen[M]ay [M]ac Club.

Old 11-24-2004, 04:14 AM Loose Cannon is offline  
Reply With Quote